Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
Abroad (travel likely)Recruiting
Conditions
Cardiomyopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mebix. Inc, Minato-ku, Tokyo, Japan
Contact: Study coordinator (Minoru Tonogai)
Study leads
Bristo Myers Squibb
Study Director
Bristo Myers Squibb